Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AZN crawled date : 2021 - 07 - 28 save search
HUTCHMED Reports 2021 Interim Results and Provides Business Updates
Published: 2021-07-28 (Crawled : 12:00) - globenewswire.com
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: -0.09%
H: 2.07%
C: 1.29%
HCM | $16.94 2.67% 2.71% 150K
|
Health Technology
|
| O: 6.45%
H: 7.99%
C: 7.76%
BGNE | $130.94 1.1% 1.24% 130K
|
Health Technology
|
| O: 3.23%
H: 13.33%
C: 12.51%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: -0.75%
H: 0.7%
C: -0.39%
results
HUTCHMED and AstraZeneca Initiate Phase II Trial of ORPATHYS® in Patients with MET Amplified Gastric Cancer
Published: 2021-07-27 (Crawled : 01:00) - chi-med.com
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: -0.4%
cancer trial
HUTCHMED and AstraZeneca Initiate Phase II Trial of ORPATHYS® in Patients with MET Amplified Gastric Cancer
Published: 2021-07-28 (Crawled : 01:00) - globenewswire.com
HCM | $16.94 2.67% 2.71% 150K
|
Health Technology
|
| O: 6.45%
H: 7.99%
C: 7.76%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: -0.75%
H: 0.7%
C: -0.39%
cancer trial
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.